Sichuan Xin Kai Yuan Pharmaceutical

Sichuan Xin Kai Yuan Pharmaceutical is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. Based in Chengdu, China, it operates as a wholly-owned subsidiary of the Sichuan Kelun Pharmaceutical Group. The company's production facilities are designed and managed according to international GMP standards, enabling it to supply high-quality chemical raw materials to global markets. Its product portfolio primarily focuses on small molecule therapies for infectious diseases, including a wide range of antifungal, antiviral, and antibacterial agents. Key products include widely used APIs such as Fluconazole, Terbinafine, and Ganciclovir. By leveraging the R&D and financial backing of the Kelun Group, Sichuan Xin Kai Yuan maintains a strong position in chemical synthesis and process optimization. The company serves as a vital link in Kelun's vertically integrated business model, ensuring the quality and supply of raw materials for finished dosage forms.